Box 1.

NHS interim clinical commissioning policy: Remdesivir for patients hospitalised with COVID-19 (adults and children aged 12 years and older)13

Eligibility criteria (in accordance with the product licence):
  • Hospitalised with COVID-19

  • With pneumonia requiring supplemental oxygen

  • Adults, and adolescents ≥12 years of age and ≥40 kg

  • eGFR ≥30 ml/min

  • Alanine aminotransferase (ALT) below 5 times the upper limit of normal at baseline

Remdesivir should be avoided in pregnancy unless clinicians believe the benefits of treatment outweigh the risks to the individual.